The U.S. Supreme Court’s conservatives suggested they are poised to curb abortion rights and uphold Mississippi’s ban on the procedure after 15 weeks of pregnancy, as the court tackled its most consequential reproductive-rights case in a generation. In arguments yesterday, all six of the court’s conservatives indicated they would let states start banning abortion far…
NEW YORK, Nov. 30, 2021 /PRNewswire/ — COTA, Inc., an oncology real-world data and analytics company, today announced four of their abstracts will be showcased at the American Society for Hematology’s (ASH) Annual Meeting & Exposition from December 11–14, 2021, in Atlanta, Georgia. COTA has the most comprehensive hematology oncology real-world data that is curated under the close guidance of leading oncologists…
During its virtual Annual Meeting 2021 held on November 9 and 10, Friends of Cancer Research (Friends) urged all stakeholders in the cancer community to work together to optimize dosing in oncology drug development to maximize benefit for patients and reduce treatment toxicity, and to abandon the “more is better” notion that a higher dose leads to higher…
Equitable access to CTs—that is, the opportunity for all patients to access CTs that may offer improved outcomes and the evidence-based standard of care treatment that CTs offer—must be a priority. Improved access in CTs will benefit individual patients, and improving inclusiveness of trial populations will benefit all patients with a given disease. Clinicians will…
FRIDAY, Nov. 12, 2021 (HealthDay News) — Despite concerns about his close ties to the drug industry, President Joe Biden is expected on Friday to nominate Dr. Robert Califf, former head of the U.S. Food and Drug Administration, to lead the agency once more. Califf, who served during the last year of the Obama administration,…
The White House tapped cardiologist Robert Califf, MD, to once again head the FDA. In a statement formally announcing his decision, President Biden praised Califf’s clinical research expertise and leadership skills, and said he is the right person to lead the agency and the country out of the COVID-19 pandemic. “As the FDA considers many…
President Joe Biden’s nomination of former FDA chief Robert Califf to once again lead the agency aims to bring a familiar face back to FDA at a critical juncture as the agency gears up for a post-COVID-19 world that is expected to include greater reliance on digital technologies and a rethinking of longstanding clinical trial policies. Since his previous…
After months of speculation – and just days before a statutory deadline – President Joe Biden on Friday announced he would nominate Robert Califf to serve as Commissioner of Food and Drugs for the second time. “I am confident Dr. Califf will ensure that the FDA continues its science and data driven decision-making. Dr.…
WASHINGTON — President Biden announced on Friday that he would nominate Dr. Robert M. Califf, a former commissioner of the Food and Drug Administration, to lead the agency again. His decision ends nearly a year of political wrangling as the White House vetted then dropped several candidates after complaints that some were too close to…
Robert Califf was nominated Friday by President Joe Biden to run the U.S. Food and Drug Administration, a move that is likely to put a one-time commissioner back at the health agency’s helm in the midst of a still-raging pandemic. Califf, a doctor and widely published scientist, is currently head of clinical strategy and policy at Alphabet Inc.’s…
